CSS LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,445
Closed -$2.47M 1456
2021
Q2
$2.47M Buy
+13,445
New +$2.31M 0.1% 208
2015
Q1
Sell
-1,300
Closed -$241K 811
2014
Q4
$241K Sell
1,300
-2,700
-68% -$500K 0.01% 602
2014
Q3
$663K Hold
4,000
0.03% 405
2014
Q2
$625K Hold
4,000
0.03% 417
2014
Q1
$609K Sell
4,000
-1,000
-20% -$159K 0.03% 369
2013
Q4
$664K Buy
+5,000
New +$600K 0.03% 351

Other funds holding ALXN

CSS LLC's ALXN Position: Q3 2021 in Review

CSS LLC sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 13,445 shares — an estimated $2.47M sold.

CSS LLC first reported a position in ALXN in Q4 2013 and held it in 6 quarters. The position peaked at $2.47M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • CSS LLC reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • CSS LLC sold 13,445 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.47M.
  • CSS LLC first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • CSS LLC's Alexion Pharmaceuticals position peaked at $2.47M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on CSS LLC's 13F filing for Q3 2021, filed 15 Nov 2021.